Reaction Details Report a problem with these data
Target
Retinol-binding protein 4
Ligand
BDBM135826
Substrate
n/a
Meas. Tech.
Binding Assay
pH
7.5±n/a
Temperature
277.15±n/a K
IC50
540±n/a nM
Comments
extracted
Citation
 Kasai, S; McGee, Jr., KF Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes US Patent  US8853215 Publication Date 10/7/2014 
Target
Name:
Retinol-binding protein 4
Synonyms:
PRBP | Plasma retinol-binding protein | RBP | RBP4 | RET4_HUMAN | Retinol-binding protein 4 | Retinol-binding protein 4 (RBP4) | spa binding assay for rbp4
Type:
Protein
Mol. Mass.:
23008.75
Organism:
Homo sapiens (Human)
Description:
P02753
Residue:
201
Sequence:
MKWVWALLLLAALGSGRAERDCRVSSFRVKENFDKARFSGTWYAMAKKDPEGLFLQDNIVAEFSVDETGQMSATAKGRVRLLNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIVDTDYDTYAVQYSCRLLNLDGTCADSYSFVFSRDPNGLPPEAQKIVRQRQEELCLARQYRLIVHNGYCDGRSERNLL
  
Inhibitor
Name:
BDBM135826
Synonyms:
US8853215, 6
Type:
Small organic molecule
Emp. Form.:
C17H25N3O3
Mol. Mass.:
319.3987
SMILES:
CC(C)(C)c1ccccc1N1CCN(CC1)C(=O)NCC(O)=O
Structure:
Search PDB for entries with ligand similarity: